A protein linked to lung inflammation, known as Krebs von den Lungen-6, or KL-6, was found to be a reliable…
Articles by Diana Campelo Delgado
The ability of Ofev (nintedanib) to improve lung function in people with progressive fibrosing interstitial lung diseases (ILDs) is…
Changes for the better in diagnosing idiopathic pulmonary fibrosis (IPF) and managing patients in the U.K. are…
Calprotectin may serve as a blood biomarker for disease severity in patients with idiopathic pulmonary fibrosis (IPF), a new…
Immune cells called macrophages can stimulate nerve-associated lung scarring (fibrosis) in pulmonary fibrosis (PF), a study reports.
Dosing has begun in a second Phase 3 trial testing FibroGen’s investigational antibody pamrevlumab in treating idiopathic pulmonary fibrosis (IPF).
The nonprofit Three Lakes Foundation and the healthcare incubator MATTER announced the four winners of the 2020…
The National Institutes of Health (NIH) has awarded a researcher at the University of Pennsylvania the K08…
The Three Lakes Foundation, a nonprofit supporting better ways of diagnosing and treating pulmonary fibrosis (PF), announced the release…
The National Heart, Lung and Blood Institute, part of the National Institutes of Health, has granted $920,000 to…